Articles

This former quant trader spent years raising alarms about Treasury-market manipulation. He says problems likely persist.

Jeffrey Tran tried to warn regulators and others about what he regarded as the ‘spoofing’ of Treasury futures, which he suspects still plagues the market for U.S. government debt

How James Murdoch made more than $27 million on Tesla’s stock — on paper

The shares that Tesla board member James Murdoch just acquired through option exercises are worth, at current prices for Tesla’s stock, $27 million more than what he paid.

This former Palantir bear changed his tune on the stock. Here’s why.

A Mizuho analyst isn’t ready to turn bullish just yet, but he abandoned his bearish call while writing that the company’s “recent execution and momentum is stunning.”

The world’s biggest money managers just issued a ‘stagflation’ warning — but look at what they’re buying

Despite their worries, managers know that there is terrible danger in missing out on a booming market.

He built one of Wall Street’s fastest-growing firms: Here are 3 questions he poses to everyone.

Barry Ritholtz’s key lessons from ‘How Not To Invest’ can help readers who have questions about their investing strategies

Wholesale prices are flat in June, PPI shows, and point to muted effect of tariffs on inflation

Wholesale prices were unchanged in June and showed only a mild effect from U.S. tariffs, adding to the growing view that trade wars won’t lead to a big increase in inflation.

Goldman Sachs’s stock gains as equities trading helps fuel a big earnings beat

Goldman Sachs’s stock rallies as its market-trading businesses shine, while rival Morgan Stanley saw investment-banking revenue slip.

Rick Santelli describes how he got a quick lesson with his first trade

The veteran CNBC reporter recalled the ups and downs of his first trade.

Ford’s stock takes a hit, as expected cost of large recall of SUVs is disclosed

Ford’s stock turned lower after the carmaker said it would cost nearly $600,000 to fix fuel injectors on up to nearly 700,000 SUVs.

Johnson & Johnson’s stock rallies after an earnings beat and raised outlook, lifting pharma stocks

Johnson & Johnson’s stock gets a boost from an earnings beat and raised full-year outlook.

Can the dollar regain its A-list status? Whatever happens will impact your wallet.

It seemed that nothing could end the U.S. currency’s reign as the “safe-haven” for financial markets. Then came the Trump tariffs.

AI will take your job in the next 18 months. Here’s your survival guide.

These moves give you a fighting chance against your smarter, faster and cheaper workplace rival. Better start now.
1 180 181 182 183 184 2,362